John Messina

3.8k total citations
80 papers, 2.7k citations indexed

About

John Messina is a scholar working on Physiology, Anesthesiology and Pain Medicine and Otorhinolaryngology. According to data from OpenAlex, John Messina has authored 80 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 25 papers in Anesthesiology and Pain Medicine and 23 papers in Otorhinolaryngology. Recurrent topics in John Messina's work include Pain Management and Opioid Use (25 papers), Sinusitis and nasal conditions (23 papers) and Pain Mechanisms and Treatments (13 papers). John Messina is often cited by papers focused on Pain Management and Opioid Use (25 papers), Sinusitis and nasal conditions (23 papers) and Pain Mechanisms and Treatments (13 papers). John Messina collaborates with scholars based in United States, Switzerland and United Kingdom. John Messina's co-authors include Ramy Mahmoud, Per G. Djupesland, Fang Xie, Richard D. Hartman, Jeffrey Veach, Ravi Anand, Martin R. Farlow, Russell K. Portenoy, Donald R. Taylor and Lothar Tremmel and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Neurology.

In The Last Decade

John Messina

73 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Messina United States	27	695	674	507	492	483	80	2.7k
Abraham Sunshine United States	27	517 0.7×	558 0.8×	223 0.4×	194 0.4×	616 1.3×	71	2.0k
Veijo Saano Finland	18	236 0.3×	386 0.6×	247 0.5×	210 0.4×	251 0.5×	58	1.7k
Raymond W. Houde United States	26	1.1k 1.5×	1.2k 1.8×	154 0.3×	724 1.5×	544 1.1×	62	2.8k
HJ McQuay United Kingdom	20	816 1.2×	841 1.2×	224 0.4×	366 0.7×	805 1.7×	41	2.3k
Arnold R. Gammaitoni United States	39	1.1k 1.6×	627 0.9×	1.3k 2.6×	1.1k 2.2×	633 1.3×	116	3.8k
Marc Kamin United States	31	1.0k 1.5×	605 0.9×	1.8k 3.6×	1.1k 2.3×	342 0.7×	61	4.0k
Ed Whalen United States	18	958 1.4×	250 0.4×	649 1.3×	163 0.3×	211 0.4×	59	2.0k
Rae Frances Bell Norway	27	1.1k 1.6×	1.3k 1.9×	396 0.8×	478 1.0×	793 1.6×	50	3.1k
Anne Estrup Olesen Denmark	27	1.1k 1.6×	572 0.8×	161 0.3×	306 0.6×	665 1.4×	123	2.7k
Judith S. Walker Australia	25	895 1.3×	182 0.3×	150 0.3×	235 0.5×	280 0.6×	53	2.3k

Countries citing papers authored by John Messina

Since Specialization

Citations

This map shows the geographic impact of John Messina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Messina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Messina more than expected).

Fields of papers citing papers by John Messina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Messina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Messina. The network helps show where John Messina may publish in the future.

Co-authorship network of co-authors of John Messina

This figure shows the co-authorship network connecting the top 25 collaborators of John Messina. A scholar is included among the top collaborators of John Messina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Messina. John Messina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wise, Sarah K., Nithin D. Adappa, Rakesh K. Chandra, et al.. (2024). EDS‐FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trials. International Forum of Allergy & Rhinology. 14(12). 1892–1903. 1 indexed citations

Palmer, James N., Nithin D. Adappa, Rakesh K. Chandra, et al.. (2024). Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2). The Journal of Allergy and Clinical Immunology In Practice. 12(4). 1049–1061. 7 indexed citations

Sacks, Harry, et al.. (2021). EDS-FLU (Exhalation Delivery System With Fluticasone) is Associated With Improved Sleep in Patients With Nasal Polyposis. Journal of Allergy and Clinical Immunology. 147(2). AB172–AB172.

Schenkel, Eric, Anju T. Peters, John Messina, Harry Sacks, & Ramy Mahmoud. (2019). Evidence for Twice-Daily Nasal Steroids Versus Once Daily for Treatment of Chronic Rhinosinusitis with Nasal Polyps. Journal of Allergy and Clinical Immunology. 143(2). AB283–AB283. 2 indexed citations

Djupesland, Per G., John Messina, & Ramy Mahmoud. (2018). Exhalation Delivery Systems (EDS) Greatly Increase Topical Delivery to Target Sites for Chronic Rhinosinusitis (CRS) Compared to Nasal Sprays or Pressurized MDIs (pMDI). Journal of Allergy and Clinical Immunology. 141(2). AB274–AB274.

Velez, Fulton, Joseph J. Medicis, John Messina, et al.. (2018). Economic Impact Associated with a Reduction in Surgical Eligibility among Adult Patients with Chronic Rhinosinusitis - A Population Cost Offset Model. Journal of Allergy and Clinical Immunology. 141(2). AB165–AB165. 4 indexed citations

Leopold, Donald A., David Elkayam, John Messina, et al.. (2018). NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. Journal of Allergy and Clinical Immunology. 143(1). 126–134.e5. 66 indexed citations

Sher, Mandel, Eric A. Mair, John Messina, et al.. (2017). EXHANCE-3: A Phase 3, Three-Month Study of Safety and Efficacy of Fluticasone Propionate Exhalation Delivery System (FLU-EDS) in Patients with Chronic Rhinosinusitis with (CRSwNP) and without Nasal Polyps (CRSsNP). Journal of Allergy and Clinical Immunology. 139(2). AB66–AB66. 7 indexed citations

Soteres, Daniel, John Messina, Jennifer Carothers, Ramy Mahmoud, & Per G. Djupesland. (2017). NAVIGATE I: A Randomized Double-Blind Trial of a Fluticasone Propionate Exhalation Delivery System (FLU-EDS) for Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Journal of Allergy and Clinical Immunology. 139(2). AB66–AB66. 3 indexed citations

10.

Offman, Elliot, et al.. (2013). Improved Pharmacokinetics of Sumatriptan With B reath P owered™ Nasal Delivery of Sumatriptan Powder. Headache The Journal of Head and Face Pain. 53(8). 1323–1333. 52 indexed citations

11.

Ashburn, Michael A., et al.. (2011). The Efficacy and Safety of Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain. Anesthesia & Analgesia. 112(3). 693–702. 37 indexed citations

12.

Farrar, John T., John Messina, Fang Xie, & Russell K. Portenoy. (2010). A Novel 12-Week Study, with Three Randomized, Double-Blind Placebo-Controlled Periods to Evaluate Fentanyl Buccal Tablets for the Relief of Breakthrough Pain in Opioid-Tolerant Patients with Noncancer-Related Chronic Pain. Pain Medicine. 11(9). 1313–1327. 22 indexed citations

13.

Passik, Steven D., et al.. (2010). Aberrant Drug-Related Behavior Observed During Clinical Studies Involving Patients Taking Chronic Opioid Therapy for Persistent Pain and Fentanyl Buccal Tablet for Breakthrough Pain. Journal of Pain and Symptom Management. 41(1). 116–125. 46 indexed citations

14.

Ritter, Samuel B., et al.. (2010). Enhancement of Ventricular Mechanics Following Bidirectional Superior Cavopulmonary Anastomosis in Patients with Single Ventricle. Journal of Cardiac Surgery. 10(2). 119–124. 2 indexed citations

15.

Nalamachu, Srinivas, Fang Xie, & John Messina. (2007). (769). Journal of Pain. 8(4). S43–S43. 2 indexed citations

16.

Portenoy, Russell K., et al.. (2006). (312/729). Journal of Pain. 7(4). S2–S2. 3 indexed citations

17.

Portenoy, Russell K., Donald R. Taylor, John Messina, & Lothar Tremmel. (2006). A Randomized, Placebo-controlled Study of Fentanyl Buccal Tablet for Breakthrough Pain in Opioid-treated Patients With Cancer. Clinical Journal of Pain. 22(9). 805–811. 162 indexed citations

18.

Portenoy, Russell K., John Messina, Fang Xie, & John F. Peppin. (2006). Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study. Current Medical Research and Opinion. 23(1). 223–233. 79 indexed citations

19.

Grossberg, George T., H.B. Stähelin, John Messina, Ravi Anand, & Jeffrey Veach. (2000). Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications. International Journal of Geriatric Psychiatry. 15(3). 242–247. 71 indexed citations

20.

Kumar, Vinod, R. Anand, John Messina, Richard D. Hartman, & Jeffrey Veach. (2000). An efficacy and safety analysis of Exelon^® in Alzheimer’s disease patients with concurrent vascular risk factors. European Journal of Neurology. 7(2). 159–169. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact